Lifastuzumab vedotin [1401812-88-1]
HY-P99705
Product group Antibodies
Overview
- SupplierMedChem Express
- Product NameLifastuzumab vedotin [1401812-88-1]
- Delivery Days Customer5
- CAS Number1401812-88-1
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity99.03
- Scientific DescriptionLifastuzumab vedotin (RG-7599; DNIB0600A) is an antibody-drug conjugate (ADC) that comprises a humanized IgG1 anti-NaPi2b monoclonal antibody (MNIB2126A) and a potent antimitotic agent, monomethyl auristatin E (MMAE), which inhibits cell division by blocking the polymerization of tubulin. Lifastuzumab vedotin has the potential for non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC) research[1].
- Storage Instruction-80°C
- UNSPSC41116161